MedPath

A RETROSPECTIVE OBSERVATIONAL STUDY IN COVID-19 PATIENTS ADMITTED TO THE ICU TO SEE WHETHER DERANGEMENT OF VARIOUS BIOMARKERS IN PATIENT BLOOD TESTS CORRELATE WITH THE OUTCOME OF THEIR ILLNESS.

Not yet recruiting
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2020/12/030049
Lead Sponsor
Maulana Azad Medical college
Brief Summary

COVID19 is a novel disease with a highly variable and unpredictable course. The pandemic is overwhelming limited intensive care resources. There is an acute need to gather and analyse clinico-demographic profiles of patients to determine the risk factors for severe illness so as to triage patients for intensive care and provide early aggressive care to at-risk patients. Various clinico-demographic indicators and numerous biomarkers have been identified as possible predictors of severe illness in western studies. There is paucity of data regarding Indian COVID19 patients.

This is a retrospective observational study in COVID19 patients admitted to the dedicated COVID ICUs of our institution from 1st May 2020 to 1st August 2020. This will be a cross sectional study performed at multiple time points.



The data will be used to describe the clinical and demographic profiles of Indian COVID19 patients with severe illness requiring intensive care.



We wish to estimate the association between values of various biomarkers of inflammation (including serum lactate dehydrogenase , serum ferritin, serum Interleukin 6, C-reactive protein, neutrophil-lymphocyte ratio, D-dimers) with survival.



We also aim to estimate the association between various biomarker data and patient demographics (including age, sex, co-morbidities), blood oxygen levels (measured with PaO2:FiO2 ratio) and need for non-invasive or invasive mechanical ventilatory support.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

ALL PATIENTS WITH LABORATORY CONFIRMED COVID19 ADMITTED TO THE INTENSIVE CARE UNIT UNDER OUR OBSERVATION DURING THE STUDY PERIOD.

Exclusion Criteria

THERE ARE NO EXCLUSION CRITERIA FOR THIS OBSERVATIONAL STUDY.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SURVIVAL OF PATIENTSBASELINE DATA COLLECTED AT TIME OF ADMISSION TO THE ICU | COURSE OF ILLNESS AND OUTCOME NOTED AT THE TIME OF DISCHARGE FROM THE ICU (RECOVERY) OR DEATH
Secondary Outcome Measures
NameTimeMethod
PROPORTION OF PATIENTS REQUIRING INVASIVE OR NON-INVASIVE MECHANICAL VENTILATIONNOTED AT THE TIME OF DISCHARGE FROM THE ICU (RECOVERY) OR DEATH

Trial Locations

Locations (1)

Lok Nayak Hospital

🇮🇳

Central, DELHI, India

Lok Nayak Hospital
🇮🇳Central, DELHI, India
Dr Karthik K Raman
Principal investigator
9650464120
raman.karthik.in@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.